跳至主要内容
临床试验/NCT00284609
NCT00284609已完成不适用

"The Effect of Rehabilitation of Type 2 Diabetes Mellitus Versus Standard Outpatient Care." A Randomized Controlled Trial.

Bispebjerg Hospital1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2006年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
180
试验地点
1
主要终点
Change in HgbA1c (Glycemic control)

研究概览

简要总结

The aim of this study is to investigate the effect of a new rehabilitation program of type 2 diabetes patients in a primary care center versus standard care in the outpatient Hospital Clinic.

详细描述

Type 2 diabetes is major and growing health care problem and is associated with premature mortality and increased morbidity. At the time of diagnosis half of the patients have cardiovascular, renal, ophthalmic or neurological disease. A recent Danish intervention study found a marked reduction in cardiovascular events and microvascular complications in a group of patients with type 2 diabetes and microalbuminuria using an intensive multifactorial pharmacologic intervention and lifestyle intervention (3). The achieved changes in lifestyle seems however to vanish after a short period. Lack of information, unawareness of the seriousness of the disease and lack of supervised training and insufficient follow-up may be of importance of the long-term outcome in these patients.

A total number of 180 patients with type 2 diabetes, will be randomized to the intervention group or to standard care.

This study tests an intensive intervention of lifestyle by a newly developed program of rehabilitation compared with routine standards in a randomized controlled design. Provided that a significant positive outcome is found, the non-pharmacologic treatment of type 2 diabetes could be optimized and inpatient hospitalization due to complications could be avoided.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Clinical diagnosis of Type 2 diabetes mellitus
  • •HgbA1c between 6,8 - 10,0%
  • •With or without one or more micro- and macrovascular or neurological complications.

排除标准

  • •HgbA1c < 6,8 and > 10,0 %
  • •Patients who have attended lifestyle intervention in the past year
  • •Patients who is planned to start treatment with insulin during intervention period
  • •Lack of motivation
  • •Patients with severe heart-, liver or kidney disease or incurable cancer

研究组 & 干预措施

1

Experimental

干预措施: Group based non-pharmacological rehabilitation (Behavioral)

2

Active Comparator

干预措施: Individual non-pharmacological rehabilitation (Behavioral)

结局指标

主要结局

Change in HgbA1c (Glycemic control)

时间窗: baseline, six month, one year, two years and three years

次要结局

  • fasting total cholesterol, triglycerides, HDL and LDL,(baseline, six month, one year, two years and three years)
  • blood pressure,(baseline, six month, one year, two years and three years)
  • weight,(baseline, six month, one year, two years and three years)
  • waist circumference,(baseline, six month, one year, two years and three years)
  • fitness test,(baseline, six month, one year, two years and three years)
  • muscle strength test,(baseline, six month, one year, two years and three years)
  • occurrence of complications,(baseline, six month, one year, two years and three years)
  • inflammatory markers,(baseline, six month, one year, two years and three years)
  • beta-cell function test (HOMA-test),(baseline, six month, one year, two years and three years)
  • endothelia cell markers,(Not yet known)
  • use of medication(baseline, six month, one year, two years and three years)
  • cost-benefit.(Not yet known)
  • Change in Quality of Life(baseline, six month, one year, two years and three years)
  • Body mass index(baseline, six month, one year, two years and three years)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验